Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.70 |
| ▸ | CA9 | Q16790 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | ESR1 | P03372 | 1/20 | 0.67 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 4/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.49 |
| ▸ | PTPRC | P08575 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28634601 | 0.94 | ALDH1A1 (0.66) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL3702995 | 0.92 | ALDH1A1 (0.63) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL3886338 | 0.90 | ALDH1A1 (0.62) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL3701001 | 0.90 | MAPT (0.67) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL6158839 | 0.87 | ALDH1A1 (0.59) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL6158969 | 0.86 | ALDH1A1 (0.58) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL28380035 | 0.86 | NPSR1 (0.69) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL6157398 | 0.86 | ALDH1A1 (0.58) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL6158520 | 0.86 | ALDH1A1 (0.61) | PKMCA12CA9ALDH1A1ESR1 | |
| SCHEMBL812682 | 0.85 | PKM (0.79) | PKMCA12CA9ALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113582947-A | Method for removing sulfonyl protection of amine | 南开大学 | 2021-11-02 | — | — | CN | disclosed |
| WO-2020011935-A1 | DIBENZOTHIOPENE SALT AS ALKINYLATING AND CYANATING AGENT | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts (DE) | 2020-01-16 | — | — | WO | disclosed |
| CN-102472966-A | Negative photosensitive resin composition, polyimide resin film using same, and flexible printed circuit board | SUMITOMO ELECTRIC INDUSTRIES | 2012-05-23 | — | — | CN | disclosed |
| US-20120118616-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, POLYIMIDE RESIN FILM USING SAME, AND FLEXIBLE PRINTED CIRCUIT BOARD | SUMITOMO ELECTRIC PRINTED CIRCUITS, INC. (JP) | 2012-05-17 | — | — | US | disclosed |
| WO-2005030730-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO-ϵ-CAPROLACTAM OR SALT THEREOF AND INTERMEDIATE FOR THE PRODUCTION | YAMAKAWA CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-04-07 | — | — | WO | disclosed |
| EP-1457487-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | Toray Fine Chemicals Co., Ltd. (JP) | 2004-09-15 | — | — | EP | disclosed |
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) | 2004-09-02 | — | — | US | disclosed |
| EP-0289780-A2 | Thermoplastic moulding compounds on the basis of polyphenylene ether | BASF Aktiengesellschaft (DE) | 1988-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TYR, DDC, TARBP1 | PKM 1651/4885CA12 4430/4885CA9 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.